Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


6 Items
Title  Creator  Group name  Publishing year 
Generation of non-genetically modified, CAR-like, NK cells Coënon et al. EquipePM 2024-07-18
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer Desroys du Roure et al. EquipePM 2024-01-30
Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody Noverraz et al. EquipePM 2023-01-05
NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells Campos-Mora et al. EquipeCTCS 2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies Antunes et al. EquipePM 2023
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors Sanchez-Martinez et al. EquipePM 2018
6 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés